Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,716 | 2,069 | 47,441 | 2,006 | 1,993 |
| Gross Profit | 2,716 | 2,069 | 47,441 | 2,006 | 1,993 |
| Operating Expenses | 15,606 | 16,296 | 21,517 | 13,840 | 28,073 |
| Operating Income | -12,890 | -14,227 | 25,924 | -11,834 | -26,080 |
| Interest Expense | 0 | 0 | 0 | 0 | 117 |
| Other Income | 976 | 961 | 847 | 159 | -2,485 |
| Pre-tax Income | -11,914 | -13,266 | 26,771 | -11,675 | -28,682 |
| Net Income Continuous | -11,914 | -13,266 | 26,771 | -11,675 | -28,682 |
| Net Income | $-11,914 | $-13,266 | $26,771 | $-11,675 | $-28,682 |
| EPS Basic Total Ops | -0.23 | -0.25 | 0.98 | -0.33 | -0.87 |
| EPS Basic Continuous Ops | -0.23 | -0.25 | 0.97 | -0.33 | -0.87 |
| EPS Diluted Total Ops | -0.23 | -0.25 | 0.98 | -0.33 | -0.87 |
| EPS Diluted Continuous Ops | -0.23 | -0.25 | 0.97 | -0.33 | -0.87 |
| EBITDA(a) | $-12,782 | $-14,114 | $26,053 | $-11,577 | $-25,786 |